X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (57) 57
male (48) 48
female (36) 36
index medicus (33) 33
endocrinology & metabolism (30) 30
adult (29) 29
diabetes (27) 27
type 2 diabetes (24) 24
middle aged (22) 22
aged (18) 18
aggregation (16) 16
blood platelets - drug effects (16) 16
platelet aggregation inhibitors - pharmacology (15) 15
diabetes mellitus, type 2 - blood (14) 14
cardiovascular disease (13) 13
insulin (13) 13
analysis (12) 12
platelet aggregation - drug effects (12) 12
blood platelets - metabolism (11) 11
nitric oxide (11) 11
pharmacology & pharmacy (11) 11
research (11) 11
diabetes mellitus, type 2 - complications (10) 10
peripheral vascular disease (10) 10
risk (10) 10
adenosine diphosphate - pharmacology (9) 9
care and treatment (9) 9
diabetes mellitus (9) 9
glomerular-filtration-rate (9) 9
glycosylated hemoglobin (9) 9
in vitro techniques (9) 9
platelet aggregation (9) 9
platelets (9) 9
albuminuria (8) 8
cardiovascular diseases (8) 8
chronic kidney-disease (8) 8
dose-response relationship, drug (8) 8
glomerular filtration rate (8) 8
glycated hemoglobin a - analysis (8) 8
mellitus (8) 8
mortality (8) 8
risk factors (8) 8
chronic kidney disease (7) 7
chronic kidney failure (7) 7
cyclic gmp - blood (7) 7
cyclic gmp - metabolism (7) 7
diabetic retinopathy (7) 7
hematology (7) 7
insulin - pharmacology (7) 7
insulin resistance (7) 7
kidney diseases (7) 7
medical research (7) 7
medicine, experimental (7) 7
original research (7) 7
physiological aspects (7) 7
prevalence (7) 7
activation (6) 6
animals (6) 6
blood platelets (6) 6
blood pressure (6) 6
body mass index (6) 6
cohort studies (6) 6
cyclic amp - blood (6) 6
diabetes mellitus, type 2 - physiopathology (6) 6
disease (6) 6
epidemiology (6) 6
hyperglycemia (6) 6
inhibition (6) 6
internal medicine (6) 6
italy - epidemiology (6) 6
adenosine (5) 5
cardiovascular diseases - complications (5) 5
cardiovascular diseases - epidemiology (5) 5
clinical trials (5) 5
complications (5) 5
complications and side effects (5) 5
cross-sectional studies (5) 5
cyclic amp (5) 5
diabetes mellitus, type 2 - epidemiology (5) 5
diabetes mellitus, type 2 - metabolism (5) 5
diabetic nephropathies - epidemiology (5) 5
diabetics (5) 5
glycated hemoglobin a - metabolism (5) 5
health risk assessment (5) 5
insulin - blood (5) 5
medicine & public health (5) 5
nitric oxide - metabolism (5) 5
patient outcomes (5) 5
physiology (5) 5
risk-factors (5) 5
therapy (5) 5
aged, 80 and over (4) 4
albumin (4) 4
all-cause mortality (4) 4
analysis of variance (4) 4
atherosclerosis (4) 4
blood glucose - analysis (4) 4
blood platelets - physiology (4) 4
blood sugar (4) 4
cardiac & cardiovascular systems (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Diabetologia, ISSN 0012-186X, 11/2018, Volume 61, Issue 11, pp. 2277 - 2289
Journal Article
BioMed Research International, ISSN 2314-6133, 2018, Volume 2018, pp. 6508709 - 11
Background. Beside the lipid-lowering effect, statins slow the progression of atherosclerosis by exerting anti-inflammatory and platelet inhibiting effects. We... 
MEDICINE, RESEARCH & EXPERIMENTAL | THERAPY | CHOLESTEROL | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | DISEASE | ATHEROSCLEROSIS | MECHANISMS | ARTERY | ENDOTHELIAL FUNCTION | STATINS | AGGREGATION | ATORVASTATIN | Hypercholesterolemia - blood | Simvastatin - administration & dosage | Humans | Middle Aged | E-Selectin - blood | Male | Biomarkers - blood | Hypercholesterolemia - drug therapy | Inflammation - blood | Inflammation - drug therapy | P-Selectin - blood | Adult | Female | Aged | Platelet Activation - drug effects | Cytokines - blood | Lipoproteins (low density) | Oxidative stress | Transcription factors | Platelet-derived growth factor | Collagens | Lipids | Cardiovascular disease | Biosynthesis | Agglomeration | Activation | Family medical history | Arachidonic acid | ADP | Eotaxin | Interleukin 6 | Reduction | Blood platelets | Atherosclerosis | IP-10 protein | Inhibition | Vascular endothelial growth factor | Drug dosages | Statins | Aspirin | Advanced glycosylation end products | Markers | Inflammation | Platelet aggregation | Interleukin 13 | Regression analysis | Low density lipoprotein | Insulin | Thrombosis | Platelet-derived growth factor BB | Cholesterol | Endothelium | E-selectin | Hypercholesterolemia | Deoxyguanosine | Diet | Arteriosclerosis | γ-Interferon | Collagen | Interleukin 10 | Diabetes | Monocyte chemoattractant protein 1
Journal Article
Journal of the American Geriatrics Society, ISSN 0002-8614, 08/2013, Volume 61, Issue 8, pp. 1253 - 1261
Objectives To assess the distribution of antihyperglycemic treatments according to age and renal function and its relationship with cardiovascular disease in... 
albuminuria | cardiovascular disease | glomerular filtration rate | age | oral hypoglycemic agents | MANAGEMENT | MYOCARDIAL-INFARCTION | RISK | GERIATRICS & GERONTOLOGY | GLOMERULAR-FILTRATION-RATE | ANTIDIABETIC AGENTS | HYPOGLYCEMIA | GERONTOLOGY | METFORMIN THERAPY | LACTIC-ACIDOSIS | PEOPLE | CHRONIC KIDNEY-DISEASE | Albuminuria - epidemiology | Life Style | Metformin - therapeutic use | Age Factors | Cardiovascular Diseases - drug therapy | Humans | Middle Aged | Diabetic Nephropathies - drug therapy | Male | Glomerular Filtration Rate - physiology | Metformin - adverse effects | Diabetes Mellitus, Type 2 - epidemiology | Albuminuria - physiopathology | Diabetic Angiopathies - physiopathology | Glomerular Filtration Rate - drug effects | Thiazolidinediones - therapeutic use | Diabetic Nephropathies - physiopathology | Cardiovascular Diseases - epidemiology | Female | Drug Therapy, Combination | Drug Utilization - statistics & numerical data | Hypoglycemic Agents - therapeutic use | Kidney Failure, Chronic - physiopathology | Cardiovascular Diseases - physiopathology | Kidney Failure, Chronic - drug therapy | Treatment Outcome | Diabetic Angiopathies - drug therapy | Health Behavior | Thiazolidinediones - adverse effects | Disease Progression | Diabetes Mellitus, Type 2 - physiopathology | Kidney Failure, Chronic - epidemiology | Albuminuria - drug therapy | Diabetic Angiopathies - epidemiology | Italy | Aged | Diabetic Nephropathies - epidemiology | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Cohort Studies | Type 2 diabetes | Medical research | Medicine, Experimental | Hypoglycemic agents | Drug therapy | Cardiovascular diseases | Diabetes therapy | Cardiovascular disease | Diabetes | Kidney diseases | Older people
Journal Article
Diabetes Care, ISSN 0149-5992, 11/2012, Volume 35, Issue 11, pp. 2317 - 2323
Journal Article
Medicinal Research Reviews, ISSN 0198-6325, 09/2015, Volume 35, Issue 5, pp. 968 - 1031
Journal Article
DIABETES CARE, ISSN 0149-5992, 10/2011, Volume 34, Issue 10, pp. 2237 - 2243
OBJECTIVE-To evaluate whether postprandial blood glucose predicts cardiovascular events and all-cause mortality in type 2 diabetes in a long-term follow-up... 
GLYCEMIA | HYPERGLYCEMIA | METAANALYSIS | MYOCARDIAL-INFARCTION | DISEASE | ENDOCRINOLOGY & METABOLISM | RISK | PEOPLE | DEATH | MELLITUS | OUTCOMES
Journal Article
Thrombosis Research, ISSN 0049-3848, 08/2019, Volume 180, pp. 74 - 85
The incretin hormone Glucagon-like peptide 1(GLP-1) plays a pivotal role in maintaining glucose homeostasis with effects also on the cardiovascular system.... 
Reactive oxygen species | Hypercholesterolemia | Platelets | Glucagon-like peptide 1 | Nitric oxide | Simvastatin | ACTIVATION | CARDIOVASCULAR OUTCOMES | HYPERLIPIDEMIA | RECEPTOR | MECHANISMS | ADHESION | THERAPY | DISEASE | PERIPHERAL VASCULAR DISEASE | HEMATOLOGY | AGGREGATION | Glucagon | Low density lipoproteins | Liraglutide
Journal Article
Cardiovascular Diabetology, ISSN 1475-2840, 05/2017, Volume 16, Issue 1, pp. 71 - 11
Mechanisms underlying the pathogenesis of ischemia/reperfusion injury are particularly complex, multifactorial and highly interconnected. A complex and... 
Antiplatelet therapy | Type 2 diabetes | Aspirin | Cardioprotection | CARDIAC & CARDIOVASCULAR SYSTEMS | RISK-FACTORS | CARDIOVASCULAR EVENTS | ISCHEMIA-REPERFUSION INJURY | CHEMERIN LEVELS | LOW-DOSE ASPIRIN | ENDOCRINOLOGY & METABOLISM | CORONARY-ARTERY-DISEASE | PRIMARY PREVENTION | ACTIVATING-FACTOR | INSULIN THERAPY | Ischemic Preconditioning, Myocardial - adverse effects | Myocardial Reperfusion Injury - etiology | Diabetes Mellitus, Type 2 - genetics | Humans | Risk Factors | MicroRNAs - metabolism | Myocardium - pathology | Treatment Outcome | Diabetes Mellitus, Type 2 - blood | Myocardial Reperfusion Injury - pathology | Animals | Signal Transduction - drug effects | Aspirin - adverse effects | Blood Platelets - metabolism | Myocardium - metabolism | Aspirin - therapeutic use | MicroRNAs - genetics | Blood Platelets - drug effects | Platelet Aggregation Inhibitors - therapeutic use | Diabetes Mellitus, Type 2 - complications | Drug Resistance | Myocardial Reperfusion Injury - blood | Myocardial Reperfusion Injury - prevention & control | Platelet Aggregation Inhibitors - adverse effects | Drugs | Therapy | Heart attacks | Laboratories | Pathogenesis | Property damage | Risk | Myocardial ischemia | Cardiovascular disease | Reperfusion | Ischemia | Blood platelets | Drug dosages | Injuries | Adenosine | Complications | Diabetes mellitus | MiRNA | Health risks | Patients | Thrombosis | Diseases | Disease prevention | MicroRNAs | Coronary vessels | Diabetes | Acute coronary syndromes | Cardiovascular diseases | Platelets
Journal Article
Diabetes, Obesity and Metabolism, ISSN 1462-8902, 08/2018, Volume 20, Issue 8, pp. 1885 - 1893
Aims To evaluate various measures of haemoglobin (Hb) A1c variability, compared with average HbA1c, as independent predictors of mortality. Materials and... 
all‐cause mortality | type 2 diabetes | cardiovascular risk factors | complications | variability | HbA1c | all-cause mortality | GLYCATED HEMOGLOBIN | GLUCOSE VARIABILITY | MICROVASCULAR COMPLICATIONS | PROSPECTIVE COHORT | GLYCEMIC VARIABILITY | HBA(1C) VARIABILITY | ENDOCRINOLOGY & METABOLISM | CARDIOVASCULAR EVENTS RIACE | CHRONIC KIDNEY-DISEASE | ITALIAN MULTICENTER | RENAL-INSUFFICIENCY | Glycated Hemoglobin A - analysis | Prevalence | Prospective Studies | Follow-Up Studies | Diabetic Cardiomyopathies - mortality | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Male | Hypoglycemia - prevention & control | Cardiovascular Diseases - complications | Diabetic Nephropathies - physiopathology | Renal Insufficiency - physiopathology | Diabetes Mellitus, Type 2 - therapy | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Diabetic Cardiomyopathies - prevention & control | Renal Insufficiency - complications | Diabetic Angiopathies - prevention & control | Diabetes Mellitus, Type 2 - complications | Kidney - physiopathology | Hyperglycemia - prevention & control | Glomerular Filtration Rate | Mortality | Risk Factors | Diabetic Angiopathies - mortality | Renal Insufficiency - mortality | Diabetic Nephropathies - mortality | Diabetes Mellitus, Type 2 - blood | Diabetes Mellitus, Type 2 - mortality | Diabetic Cardiomyopathies - epidemiology | Diabetic Angiopathies - epidemiology | Italy - epidemiology | Aged | Cohort Studies | Type 2 diabetes | Complications and side effects | Medical research | Patient outcomes | Analysis | Glycosylated hemoglobin | Medicine, Experimental | Risk factors | Renal insufficiency | Diabetes mellitus | Hemoglobin | Diabetes | Health risk assessment | Diabetes mellitus (non-insulin dependent)
Journal Article